Sanofi backs Altesa US$75m rhinovirus series B

Sanofi has backed Altesa BioSciences in a US$75m series B round for the rhinovirus-focused biotech led by former acting FDA commissioner Brett Giroir.

Read more here.

Previous post
Back to list
Next post